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bile stroke team (MST-ICU) during an equal observation pe-
riod of 27 months. Secondary objectives included compar-
ing mortality and the proportion of patients with excellent 
outcomes (modified Rankin Score (mRS) 0–1). Equal cardio-
vascular monitoring was offered in patients admitted in both 
SI-SU and MST-ICU.  Results: 458 patients were treated in the 
SI-SU and compared to the MST-ICU (n = 370) cohort. The 
proportion of death and dependency after 3 months was sig-
nificantly improved for patients in the SI-SU compared to 
MST-ICU (p < 0.001; aOR = 0.45; 95% CI: 0.31–0.65). The shift 
analysis of the mRS distribution showed significant shift to 
the lower mRS in the SI-SU group, p < 0.001. The proportion 
of mortality in patients after 3 months also differed between 
the MST-ICU and the SI-SU (p < 0.05), but after adjusting for 
confounders this association was not significant (aOR = 0.59; 
95% CI: 0.31–1.13). The proportion of patients with excellent 
outcome was higher in the SI-SU (59.4 vs. 44.9%, p < 0.001) 
but the relationship was no more significant after adjust-
ment (aOR = 1.17; 95% CI: 0.87–1.5).  Conclusions: Our study 
shows that moving from a stroke team in a monitored set-
ting (ICU) to an organized stroke unit leads to a significant 
reduction in the 3 months unfavorable outcome in patients 
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 Abstract 
 Background and Purpose: Precise mechanisms underlying 
the effectiveness of the stroke unit (SU) are not fully estab-
lished. Studies that compare monitored stroke units (semi-
intensive type, SI-SU) versus an intensive care unit (ICU)-
based mobile stroke team (MST-ICU) are lacking. Although 
inequalities in access to stroke unit care are globally improv-
ing, acute stroke patients may be admitted to Intensive Care 
Units for monitoring and followed by a mobile stroke team 
in hospital’s lacking an SU with continuous cardiovascular 
monitoring. We aimed at comparing the stroke outcome be-
tween SI-SU and MST-ICU and hypothesized that the bene-
fits of SI-SU are driven by additional elements other than car-
diovascular monitoring, which is equally offered in both care 
systems.  Methods: In a single-center setting, we compared 
the unfavorable outcomes (dependency and mortality) at 
3  months in consecutive patients with ischemic stroke or 
spontaneous intracerebral hemorrhage admitted to a stroke 
unit with semi-intensive monitoring (SI-SU) to a cohort of 
stroke patients hospitalized in an ICU and followed by a mo-
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with an acute ischemic or hemorrhagic stroke. Cardiovascu-
lar monitoring is indispensable, but benefits of a semi-inten-
sive Stroke Unit are driven by additional elements beyond 
intensive cardiovascular monitoring. This observation sup-
ports the ongoing development of Stroke Centers for effi-
cient stroke care .  © 2015 S. Karger AG, Basel 
 Introduction 
 The effectiveness of a dedicated stroke unit (SU) has 
been confirmed by large observational studies of routine 
clinical practice  [1–3], and a geographically defined SU 
with a dedicated specialized team is associated with better 
clinical outcome than other therapeutic strategies like 
mobile stroke teams in non-monitored settings  [4]. The 
precise mechanisms measured in terms of clinical out-
come and mortality of the SU remains partially contro-
versial and not fully established. The major benefits of a 
comprehensive acute stroke care are the monitoring of 
cardiovascular parameters, adherence to treatment pro-
tocols, training of the staff, presence of a dedicated stroke 
specialist, and early integration of neurorehabilitation 
programs  [5–9] .
 Although inequalities in access to stroke unit care are 
globally improving  [10] , acute stroke patients may be ad-
mitted to Intensive Care Units (ICU) for monitoring and 
followed by a mobile stroke team in hospitals lacking an 
SU with continuous cardiovascular monitoring. Com-
parisons of care between a dedicated SU (with or without 
cardiovascular monitoring) and in ward departments 
(general medicine or general medicine with rehabilita-
tion) are abundant  [11, 12] . Studies that compare moni-
tored SUs (semi-intensive type) versus non-monitored 
structures are rare  [7, 9] , and a comparison between a 
geographically monitored SU (semi-intensive type, SI-
SU) and a monitored (ICU-based) mobile Stroke Team 
system (MST-ICU) is lacking. We hypothesized that the 
exhaustive cardiovascular monitoring, as offered by an 
MST-ICU management approach, is not sufficient to ex-
plain the benefit of specialized stroke care. We report here 
the experience of a single hospital before and after the 
creation of a semi-intensive SU.
 Methods 
 The study is designed with a  ‘before-after’ approach to observe 
the functional outcomes, in terms of dependence (defined as mod-
ified Rankin Scale (mRS) of 3–5) and 3-month mortality (mRS of 
6), in consecutive patients diagnosed with ischemic stroke or spon-
taneous intracerebral hemorrhage admitted to an SI-SU with ded-
icated specialized staff over 27 months. These results were com-
pared with a retrospective cohort of patients hospitalized for stroke 
monitoring in the MST-ICU setting. The functional outcomes 
were pre-specified prior to the start of the study. All patients in the 
study were entered prospectively in a specified database (RADIAL, 
 R egistry  A nd  D atabase of acute  I schemic and hemorrhagic  A ttacks 
in  L ugano). The web-based database was created before the begin-
ning of the study. The study’s main objective was to determine if 
the proportion of patients with unfavorable outcome (defined as 
3 months mRS Scale 3–5 or mortality) differed between the period 
before and the period after the onset of the SI-SU. Secondary ob-
jectives included comparing mortality and the proportion of pa-
tients with excellent outcomes (mRS 0–1). Explorative analyses 
were carried out to assess potential predictors of unfavorable out-
come. Additional, explorative subgroup analyses were performed 
with respect to the effects of the SI-SU on dependence and mortal-
ity after 3 months.
 Characterization of Treatment Concepts 
 All principal treatment processes attributed to the two differ-
ent stroke treatment concepts are summarized in  table 1 . Cardio-
vascular monitoring was equally offered in both SI-SU and MST-
ICU.
 Semi-Intensive Stroke Unit (SI-SU) 
 The SI-SU is a 6-monitored bed unit located in the Neurocenter 
of Southern Switzerland, in the Ospedale Regionale di Lugano, 
Switzerland that is a certified Comprehensive Stroke Center, con-
sistent with the EUSI/ESO  [11, 13] and Swiss Stroke Society  [14] 
criteria. In the SI-SU, the responsible medical team is represented 
by stroke neurologists (with National Certification for Cerebro-
vascular Diseases; http://www.sgkn.ch), dedicated team nurses 
with stroke experience, internists and a multidisciplinary neurore-
habilitation team (for details see  table 1 ). Patients were monitored 
in the unit for a minimum of 24 h. Patients, according to clinical 
evolution, were subsequently admitted to the adjacent neurology 
ward under the care of the same previously described team.
 Mobile Stroke Team with Monitored Stroke Beds in the 
Intensive Care Unit (MST-ICU) 
 In this care concept, the stroke patient is treated by a multidis-
ciplinary care team in the ICU and by a mobile stroke team repre-
sented by stroke neurologists (with National Certification for 
Cerebrovascular Diseases; http://www.sgkn.ch), serving as consul-
tants. Additionally, a mobile multidisciplinary neurorehabilitation 
team followed these patients, for details see  table 1 . This unit also 
has access to neurosurgeons, neuroradiologists, and vascular sur-
geons present in the hospital. Patients were monitored in the unit 
for a minimum of 24 h. After the ICU, patients were transferred to 
the departments of Neurology (approx. 90%) or Internal Medicine 
(10%) with neurology following as a consulting team.
 Patient Selection 
 Patients included those admitted to the SI-SU or MST-ICU 
with a diagnosis of acute cerebrovascular ischemic stroke (AIS) or 
spontaneous intracerebral hemorrhage (ICH). Informed written 
consent of patients or of their relatives was required. Criteria for 
inclusion were clinical and/or radiologic diagnosis of AIS or ICH, 
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hospitalization occurred within the first 24 h of onset of symptoms, 
and age >18. Exclusion criteria were patients already institutional-
ized or severely disabled (with documented mRS >3) before the 
AIS or ICH, preexisting dementia, severe comorbidity (life expec-
tancy <12 months) or in which an early decision (within 48 h) of 
care withdrawn is made (non-maximalist therapy, neurological 
team always involved in the decision). Patients with subarachnoid 
hemorrhage or other secondary hemorrhage (e.g. arteriovenous 
malformation) as well as patients with TIA were also excluded 
from analysis. The selection criteria of subjects recruited during 
the before period (MST-ICU)  were identical to those of the period 
after (SI-SU).
 Data Collection 
 The data was collected by the treating neurology team in the 
acute phase of the stroke (first 7 days) and completed with a follow-
up at 3 months. The monitoring during the interim (3 months) was 
done through independent clinical assessment or telephone survey 
by trained and certified personnel. The data thus collected were 
included in the prospective database. The following data were re-
corded: sociodemographic characteristics (age, gender), vascular 
risk factors, stroke severity (by NIHSS), degree of disability ac-
cording to the mRS  [15, 16] before stroke onset and clinical stroke 
classification according to the Trial of Org 10172 in Acute Stroke 
Treatment (TOAST) protocol  [17, 18] .
 Ethics, Role of the Funding Source 
 The local Ethics Committee examined and approved the study 
protocol (CE number 2278). The sponsor of the study (EOC) had 
no role in study design, data collection, data analysis, data inter-
pretation, or writing of the report. All patients gave informed con-
sent to participate in the study and be registered in the RADIAL 
database.
 Statistical Analysis 
 The sample size was calculated based on the expected primary 
endpoints of mortality and dependency at three months between 
the two cohorts. In particular, an absolute reduction of 10% of the 
proportions of unfavorable outcome was expected to be clinically 
relevant . Based on these assumptions, 350 patients per group were 
required to achieve a power of 80% with a significance level of 5% 
(χ 2 test). We created dichotomous variables for the outcomes after 
three months: death and dependency (unfavorable outcome, de-
fined as mRS 3–6), mortality defined as mRS = 6, and excellent 
outcome defined as mRS  ≤ 1. We also performed a  shift analysis of 
the mRS, according to a recent publication  [19] . In particular, we 
compared the distribution of the mRS between the groups using 
Cochran-Mantel-Haenszel (CMH) statistics with the computation 
option of the modified RIDIT scores, which represent the expected 
values of the order statistics for the uniform distribution on (0, 1). 
Means are given with standard deviations (±SD). The association 
between categorical variables was investigated using the mean of 
chi-squared test (χ 2 ). Numerical variables were compared using 
the mean of the Student’s  t test and when applicable using the 
Mann-Whitney U Test. All tests were two-tailed and considered 
significant if p < 0.05. Univariable logistic regression models were 
used to determine the effect of hospitalization in the SU on depen-
dency and mortality and on mortality at 3 months by calculating 
the odds ratio (OR) and their relative 95% confidence intervals 
(95% CI).
 A multivariable logistic regression model was used to explore 
the possible risk factors related to the dependency and mortality 
after 3 months. The results were adjusted for age, sex, and hospi-
talization in SI-SU. Based on the outcome of this analysis, subse-
quent models used to determine the effect of the hospitalization in 
the SI-SU on outcome at 3 months were adjusted for age, sex, 
 NIHSS on admission, type of stroke, and diabetes.
Table 1.  Stroke treatment processes definition
Intervention SI-SU MST-ICU
Beds (medical responsible) Stroke unit (neurology dept.) Intensive care (ICU dept.)
Cardiovascular monitoring Blood pressure, heart rhythm, blood sugar, 
oxygen saturation, fluid balance
Blood pressure, heart rhythm, blood sugar, 
oxygen saturation, fluid balance
Neurological monitoring GCS, NIHSS, and ad hoc GCS, NIHSS, and ad hoc
Vascular neurology team On site Mobile unit (consultant/on call)
Internal medicine consultants On call On site
Cardiology consultants On call On call
Neuroradiology In house, on call In house, on call
Neurosurgery In house, on call In house, on call
Neurosonology On site, on call In house, on call
Stroke guidelines/treatment pathways Present Present
Acute neuro-rehabilitation program On site and on call On call
Speech and language therapists On site and on call On call
Neuro-rehabilitation team visit Twice a week and on call On call
Stroke-rehabilitation team meeting Once a week Absent
Neuropsicology consulting On site On call
Stroke training/update conferences Frequent (>10/year) Less frequent (<10/year)
Stroke focused nursing program Present Partially present
Stroke research Present Present
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 Explorative subgroup analysis models were made for age, gen-
der, stroke severity on admission (NIHSS), and type of stroke 
(ischemic or hemorrhagic). A sensitivity analysis on dependency 
and death was performed which included patients who were previ-
ously excluded because of severe comorbidities and care with-
drawn. All statistical analyses were performed in SPSS (IBM) 20.0 
for Windows.
 Results 
 For the MST-ICU period,  patients were enrolled from 
2008 to 2010. In 27 months a total of 477 patients were 
admitted. For the SI-SU period patients were enrolled 
from 2010 (start of the SI-SU phase, with no transition 
phase) until 2012. In 27 months a total of 707 patients 
were admitted. Overall, 350 patients did not fulfill the in-
clusion criteria for enrollment into the study. Causes for 
exclusion are listed in  figure 1 . A total of 828 patients 
where thus included in the analyses, 370 admitted to the 
MST-ICU and 458 to the SI-SU. In  table 2 , we reported 
baseline characteristics for the two groups ( before , MST-
ICU and  after , SI-SU) included in the study. Multivari-
able exploratory analysis of possible predictors of unfa-
vorable outcome showed that NIHSS >5 (NIHSS 5–15, 
OR = 3.48; 95% CI: 2.36–5.12 and NIHSS >15, OR = 29.8; 
95% CI: 16.17–54.89), hemorrhagic stroke (OR = 3.61; 
95% CI: 2.02–6.45), and diabetes (OR = 1.63; 95% CI: 
1.08–2.5) were significant factors increasing the risk of 
unfavorable outcome.
 The rate of unfavorable outcome (dependency and 
death) in patients after 3 months differed between the 
MST-ICU and the SI-SU (p < 0.001;  table 3 ), with a crude 
odds ratio (OR) of 0.45 (95% CI: 0.33–0.61), indicating a 
decreased proportion of patients with unfavorable out-
comes associated with a hospitalization in the SI-SU. Af-
ter adjusting for age, sex, NIHSS on admission, type of 
stroke and diabetes this association remained significant 
(aOR = 0.45; 95% CI: 0.31–0.65). The rate of mortality in 
patients after 3 months differed between the MST-ICU 
and the SI-SU ( table 3 ), with a crude odds ratio (OR) of 
0.51 (95% CI: 0.28–0.92), indicating a decreased propor-
tion of mortality in patients associated with a hospitaliza-
tion in the SI-SU. After adjusting for age, sex, NIHSS on 
admission, type of stroke and diabetes, however, this as-
438 outcome
survived
458 outcome all 370 outcome all
4 lost to follow-up 2 lost to follow-up
340 outcome
survived
372 patients
included
462 patients
included
30 died20 died
   105 patients excluded:
 53 TIA
   6 other stroke type
 18 stroke not confirmed
 19 severely disabled (mRS >3)
      before stroke
   9 severe comorbidities/care
      withdrawn
    245 patients excluded:
 157 TIA
    4 other stroke type
  38 stroke not confirmed
  34 severely disabled (mRS >3)
       before stroke
 12 severe comorbidities/care
      withdrawn
707 patients
screened
477 patients
screened
SI-SU MST-ICU
Baseline characteristics
and
follow-up 3 months after 
stroke onset:
Mortality
Disability
Analysis:
 Fig. 1. Patient participation flow chart. 
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sociation was no longer significant (aOR = 0.59; 95% CI: 
0.31–1.13). Patients in the SI-SU period showed a higher 
proportion of excellent outcomes at three months follow-
up when compared to patients enrolled in the MST-ICU 
( table 3 ).  Figure 2 shows the details of the mRS propor-
tions at three months for the two groups of patients. The 
shift analysis of the mRS distribution showed significant 
shift to the lower mRS in the SI-SU group, p < 0.001. The 
Hodges-Lehman median difference in the scores was 1 
(95% CI: 0–1). A sensitivity analysis, also including the 
Table 3.  Clinical outcome (modified Rankin Scale, mRS) after 3 months follow-up with OR for SI-SU treatment 
and proportions of stroke patients
OR (95% CI) aOR (95% CI)  SI-SU 
(n = 458)
MST-ICU 
(n = 370)
n/total % n/total %
Unfavorable outcome (mRS 3–6) 0.45 (0.33–0.61) 0.45 (0.31–0.65) 113/458 24.7** 155/370 41.9
Mortality (mRS = 6) 0.51 (0.28–0.92) 0.59 (0.31–1.13) 20/458 4.4* 30/370 8.1
Excellent outcome (mRS 0–1) 0.99 (0.89–1.09) 1.17 (0.87–1.5) 272/458 59.4** 166/370 44.9
mRS at 3 months, mean (±SD) 1.6 [1.6]** 2.2 (1.9)
 * p < 0.05; ** p < 0.001.
Table 2.  Baseline characteristics of studied population
SI-SU (n = 457 or 458) MST-ICU (n = 368 or  370)
n/total % n/total %
Female 196/458 42.8 142/370 38.4
Age, mean (±SD) 70.7 (12.8) 70.1 (14.6)
18–55 62/457 13.6 60/368 16.3
56–74 192/457 42.0 136/368 37.0
75–84 141/457 30.9 124/368 33.7
≥85 62/457 13.6 48/368 13.0
NIHSS on admission
0–4
5–15
>15
263/458
143/458
52/458
57.4
31.2
11.4
193/370
114/370
63/370
52.2
30.8
17.0
Stroke type
Ischemic
Hemorrhagic
420/458
38/458
91.7
8.3
324/370
46/370
87.6
12.4
TOAST classification
Macroangiopathy
Microangiopathy
Cardioembolic
Other
Unknown
64/458
106/458
144/458
47/458
97/458
14.0
23.1
31.4
10.3
21.2
67/370
89/370
128/370
49/370
37/370
18.1
24.1
34.6
13.2
10.0*
Comorbidities/risk factors
Diabetes mellitus 86/458 18.8 93/370 25.1*
Atrial fibrillation 84/458 18.3 91/370 24.6*
Current smoking 125/458 27.3 99/370 26.8
Previous TIA/stroke 68/458 14.8 52/370 14.1
Hypertension 340/458 74.2 267/370 72.2
Dyslipidemia 310/458 67.7 204/370 55.1**
 * p < 0.05; ** p < 0.001.
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patients excluded for severe comorbidities/care with-
drawn, confirmed the association between admission in 
the SI-SU and a decreased rate of patients with unfavor-
able outcomes (OR = 0.47; 95% CI: 0.35–0.63).
 Multivariable analyses of subgroups, used to deter-
mine the effects of the hospitalization in the SU on depen-
dency and death (online suppl. fig. 3; www.karger.com/
doi/10.1159/000369919) showed that all subgroups of pa-
tients analyzed benefited from being hospitalized in the 
SI-SU. Similarly, we found that hospitalization in the SI-
SU was associated with reduced mortality, even if this 
 effect was not significant (online suppl. fig.  3). In the 
MST-ICU period (27 months), 22 (5.9%) patients re-
ceived thrombolysis therapy (3 intra-arterial, 19 intrave-
nous), which corresponds to a rate of 0.81 lysis per month. 
In the SI-SU period (27 months), this rate is increased to 
2 lysis per month, with a total of 63 thrombolysis (14% of 
patients, 8 intra-arterial, 55 intravenous lyses) registered 
over 27 months (p < 0.001). The number of patients trans-
ferred from outside hospitals (included in the same care 
system EOC) also increased from 38/364 (10.4%) versus 
87/449 (19.4%, p < 0.001).
 Discussion 
 We have shown that moving from a stroke team in a 
monitored setting (MST-ICU) to an organized Stroke 
Unit (SI-SU) leads to a significant reduction in the 
3 months unfavorable outcomes in patients with an acute 
ischemic or hemorrhagic stroke.
 Assuming that the cardiovascular monitoring algo-
rithm is offered equally in both SI-SU and MST-ICU, the 
study supports the hypothesis that the benefits of special-
ized SUs are explained by elements other than intense 
 cardiovascular monitoring. Given the current stroke care 
environment, a randomized trial to prove the effective-
ness of the SI-SU, although theoretically needed, would 
likely be unethical. In this context, we attempted to better 
understand the effectiveness of an organized comprehen-
sive stroke center in a  real-world setting (of high devel-
oped medical countries) in which acute stroke patients 
may be hospitalized in an ICU for monitoring if a moni-
tored Stroke Unit is not available. Monitoring of physio-
logical parameters in the acute phase of ischemic stroke is 
an important management tool that can improve signifi-
cantly the quality of care provided: this monitoring allows 
easier detection and correction of complications, conse-
quently having a favorable effect on outcome. Because of 
this, monitoring has been established as a fundamental 
component of SU care and benefits  [9, 20] . Although the 
importance of monitoring is not debated, this study tells 
that the effects of the SI-SU are likely to be driven by ad-
ditional elements, which are missing in an MST-ICU 
management. The main differences between SI-SU and 
MST-ICU (see  table 1 ) are (1) the primary medical re-
sponsibility (neurologist in SI-SU and intensive care phy-
sicians in MST-ICU; (2) the presence of an on-site vascu-
lar neurology team in SI-SU (versus a consulting role in 
MST-ICU); (3) a more developed acute neuro-rehabilita-
tion program in SI-SU with regular neuro-rehabilitation 
team visits on site (2/week) and a regular stroke team and 
rehabilitation meeting (1/week); and (4) in SI-SU the 
stroke training/update conferences are more frequent 
(>10/year) along with stroke-focused nursing programs. 
As a consequence, likely factors in the SI-SU are a conti-
nuity of the primary neurology team and a harmonized 
neuro-rehabilitation program. A structured acute neuro-
rehabilitation program with regular neuro-rehabilitation 
team visits, on-site speech and language therapists, regu-
 Fig. 2. Distribution of mRS at 3 months ac-
cording to different treatment concept al-
locations. Comparison of the mRS distri-
bution showed significant shift to the lower 
mRS in favor of the SI-SU group, p < 0.001. 
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lar multidisciplinary stroke-rehabilitation team meetings 
and personalized neuropsychology consulting contribute 
to more cohesive care. This may be influenced by more 
training/updates on stroke,  a stroke-focused nursing pro-
gram, and active stroke research. In our study, the aug-
mented numbers of thrombolysis and transfers from 
 regional hospitals seemed to be indicative of this trend. 
We can speculate that the creation of an SI-SU is associ-
ated with a ‘new perception and culture of stroke care’.
 Our data also demonstrated a nonsignificant reduc-
tion of mortality in the SI-SU group. A previous nonran-
domized study showed that a semi-intensive monitored 
SU when compared to a non-monitored conventional SU 
is efficacious in terms of mortality  [21] with a reduction 
from 27.0 to 15.6%. The rate of 3 months mortality in our 
population was substantially low (reduction to 4.4 from 
8.1 than the Cochrane Review’s rate or other previous re-
ports)  [7, 12, 21–24] . We believe that the highly intensive 
monitored caring in both treatment concepts may be a 
major reason for our low in-hospital mortality. For this 
reason it may be easier to prove superiority by comparing 
an SI-SU system to conventional non-monitored ward 
care. The absence of significant difference of the SI-SU 
system on mortality is probably driven by the low number 
of deaths in the two groups and the fact that the study was 
not powered for a comparison on mortality alone.
 We were concerned that the difference of stroke sever-
ity, although nonsignificant, could be a confounding vari-
able. Explorative analyses on predictors for unfavorable 
confirmed the importance of taking into account the ef-
fects of NIHSS on admission, type of stroke, and diabetes. 
Given this, we adjusted our multivariate analysis model 
according to these assumptions. Additionally, subgroup 
analyses revealed that all investigated groups of patients 
with respect to age, NIHSS, and stroke type were associ-
ated with a better outcome if hospitalized in the SI-SU, 
even if it was not significant. This lack of significance is 
probably explained by the fact that the study was not pow-
ered for this analysis and because of the relatively low 
number of patients in each sub-group.
 We concede that our study has several limitations. The 
design allows for a degree of selection bias. To minimize 
the bias selection, we excluded patients who did not fulfil 
the admission criteria. As a consequence (that we con-
sider marginal in our study), only those patients allocated 
in the ICU or SI-SU based on bed availability were in-
cluded in the analysis. Excluding patients with a rapid 
decision to abstain from aggressive treatment may have 
varied in the two different periods, because of 2 different 
teams directly responsible for patient care. Nevertheless, 
we performed a sensitivity analysis including these pa-
tients, which confirmed the main results. As previously 
discussed, the present results must also be cautiously in-
terpreted, since this is not a randomized study. We also 
acknowledge that theoretically the comparison of a treat-
ment in two consecutive periods may be associated with 
a better outcome in the most recent period because of 
optimization of care, but we think that this issue is in our 
study less plausible because the two time frames are in 
close proximity to one another and because of the high 
standard of care in the two settings. In addition, the re-
sults of the ECASS III study were associated immediately 
(September 2008) with a change in practice (IV throm-
bolysis allowed up to 4.5 h), already in the MST-ICU pe-
riod. The amount of tPA in the 3–4.5 h time window did 
not differ between the SI-SU and MST-ICU periods (11% 
(2/19) and 14% (8/55), respectively; p = 0.658).
 While our study concentrated on the clinical outcomes 
between two models of care, other topics such as econom-
ical and cost-effectiveness between care systems are also 
important for optimizing patient care. These assessments 
reside outside the scope of this study. In our case, the de-
cision to create and recognize at federal level stroke cen-
ters and stroke units was made by the conference of 
the directors of the Health Ministers (GDK) in 2011 and 
led to the definition of certification criteria and proce-
dures by the Swiss Federation of Clinical Neurosocieties 
(SFCNS)  [14] . Nevertheless, national health reimburse-
ment strategies that valorize specialized stroke care in 
Stroke Centers deserve further study.
 Summary 
 Our single-center study shows that moving from a 
stroke team in a monitored setting (ICU) to an organized 
stroke unit with semi-intensive care monitoring (SI-SU) 
leads to a significant reduction of unfavorable outcomes 
in patients with an acute ischemic or hemorrhagic stroke. 
Cardiovascular monitoring is indispensable, but we think 
that the benefits are driven by additional elements offered 
by neurological and multidisciplinary competent team 
synergy, focused in a circumscribed setting (Stroke Unit 
or Center). This ‘stroke-focused’ approach offers better 
stroke management by continuity of the primary team, a 
multidisciplinary neuro-rehabilitation program, and 
comprehensive medical, nursing protocols, and treat-
ment algorithms. Nevertheless, not all the beneficial 
mechanisms of an SI-SU concept are fully understood 
and future detailed studies addressing this issue are need-
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ed. Meanwhile, our study supports the creation and pro-
motion of Stroke Centers (or Units) for contemporary 
and efficient stroke care.
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